학술논문
1197P Changes in the concentration of EGFR-mutated (EGFR-M+) plasma DNA in the first hours of TKI therapy allow the prediction of tumour response in patients with EGFR-M+ NSCLC
Document Type
Abstract
Author
Source
In Annals of Oncology September 2020 31 Supplement 4:S787-S787
Subject
Language
ISSN
0923-7534